Lp-PLA2-IN-1
CAS No. 1420367-28-7
Lp-PLA2-IN-1( Lp-PLA2 -IN-1 | Lp-PLA2 inhibitor 1 )
Catalog No. M26743 CAS No. 1420367-28-7
Lp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 70 | In Stock |
|
| 10MG | 112 | In Stock |
|
| 25MG | 202 | In Stock |
|
| 50MG | 299 | In Stock |
|
| 100MG | 418 | In Stock |
|
| 200MG | 589 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLp-PLA2-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionLp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation.
-
DescriptionLp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation. Lp-PLA2 -IN-1also inhibits to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example, atherosclerosis, Alzheimer's disease.(In Vitro):Lp-PLA2 is a phospholipase A2 enzyme involved in the hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2 travels with LDL and rapidly cleaves oxidized phosphatidylcholine molecules derived from the oxidation of LDL.
-
In VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2 enzyme involved in hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2 travels with low-density lipoprotein (LDL) and rapidly cleaves oxidized phosphatidylcholine molecules derived from the oxidation of LDL.
-
In Vivo——
-
SynonymsLp-PLA2 -IN-1 | Lp-PLA2 inhibitor 1
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorAndrogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1420367-28-7
-
Formula Weight468.384
-
Molecular FormulaC21H17F5N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 25 mg/mL (53.38 mM)
-
SMILESCN1CCCn2c1cc(OCc1cc(F)c(Oc3ccc(nc3)C(F)(F)F)c(F)c1)nc2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cutler C, et al. Equine metabolism of the selective androgen receptor modulator AC-262536 in vitro and in urine, plasma and hair following oral administration. Drug Test Anal. 2021 Feb;13(2):369-385.
molnova catalog
related products
-
AK106-001616
AK106-001616 (AK 106-001616) is a potent and selective inhibitor of cytosolic phospholipase A2 (cPLA2) with IC50 of 3.8 nM (human cPLA2 enzyme).
-
Compound 48/80 trihy...
Compound 48/80 trihydrochloride (C48/80 trihydrochloride) is a mixture of N-methyl-p-methoxyphenethylamine and formaldehyde produced via a condensation reaction.
-
VU 0364739 hydrochlo...
VU 0364739 hydrochloride (VU 0364739 HCl) is a selective and potent inhibitor of phospholipase D2 (PLD2) with IC50s of 20 and 1500 nM for PLD2 and PLD1, respectively.
Cart
sales@molnova.com